LIFE - Atyr Pharma Inc
Close
1.9
0.050 2.632%
Share volume: 269,477
Last Updated: Tue 04 Jun 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.85
0.05
2.70%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-10 | 2022-08-15 | 2022-11-14 | 2023-03-14 | 2023-05-09 | 2023-08-09 | 2023-11-09 | |
| Assets | ||||||||
| Total Assets | 104.776 M | 96.016 M | 96.055 M | 95.786 M | 136.838 M | 132.747 M | 125.069 M | |
| Current Assets | 103.117 M | 93.355 M | 84.633 M | 80.871 M | 119.447 M | 114.431 M | 107.298 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 4.451 M | 4.801 M | 7.259 M | 14.725 M | 5.062 M | 5.850 M | 5.167 M | |
| Short Term Investments | 4.451 M | 4.801 M | 7.259 M | 14.725 M | 5.062 M | 5.850 M | 5.167 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 98.666 M | 88.554 M | 77.374 M | 66.146 M | 114.385 M | 108.581 M | 102.131 M | |
| Total Non-current Assets | 1.659 M | 2.661 M | 11.422 M | 14.915 M | 17.391 M | 18.316 M | 17.771 M | |
| Property Plant Equipment | 433.000 K | 558.000 K | 1.275 M | 3.059 M | 5.167 M | 5.812 M | 5.644 M | |
| Other Assets | 1.226 M | 1.370 M | 7.908 M | 8.691 M | 9.034 M | 9.085 M | 8.676 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 104.776 M | 96.016 M | 96.055 M | 95.786 M | 136.838 M | 132.747 M | 125.069 M | |
| Total liabilities | 6.226 M | 9.381 M | 18.871 M | 24.322 M | 26.959 M | 26.510 M | 26.679 M | |
| Total current liabilities | 6.269 M | 9.260 M | 11.213 M | 13.862 M | 13.654 M | 12.368 M | 12.881 M | |
| Accounts Payable | 1.563 M | 1.674 M | 3.129 M | 3.106 M | 3.965 M | 516.000 K | 2.043 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 1.012 M | 976.000 K | 815.000 K | 894.000 K | 801.000 K | 1.064 M | 1.233 M | |
| Long term debt | 133.000 K | 298.000 K | 7.836 M | 10.640 M | 13.486 M | 14.327 M | 13.985 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | -176.000 K | -177.000 K | -178.000 K | -180.000 K | -181.000 K | -185.000 K | -187.000 K | |
| Total Shareholder equity | 98.550 M | 86.635 M | 77.184 M | 71.464 M | 109.879 M | 106.237 M | 98.390 M | |
| Common stock | 27.818 M | 28.063 M | 28.663 M | 29.133 M | 41.898 M | 55.144 M | 57.885 M | |
| Retained earnings | -384.449 M | -396.869 M | -410.113 M | -417.634 M | -429.585 M | -441.923 M | -453.263 M |